KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Revenue (2017 - 2025)

Historic Revenue for Moderna (MRNA) over the last 9 years, with Q3 2025 value amounting to $1.0 billion.

  • Moderna's Revenue fell 4543.5% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year decrease of 5550.24%. This contributed to the annual value of $3.2 billion for FY2024, which is 5274.53% down from last year.
  • Latest data reveals that Moderna reported Revenue of $1.0 billion as of Q3 2025, which was down 4543.5% from $142.0 million recorded in Q2 2025.
  • Moderna's 5-year Revenue high stood at $7.2 billion for Q4 2021, and its period low was $108.0 million during Q1 2025.
  • Moreover, its 5-year median value for Revenue was $1.9 billion (2023), whereas its average is $2.6 billion.
  • As far as peak fluctuations go, Moderna's Revenue surged by 2411250.0% in 2021, and later crashed by 9275.64% in 2023.
  • Quarter analysis of 5 years shows Moderna's Revenue stood at $7.2 billion in 2021, then decreased by 29.5% to $5.1 billion in 2022, then tumbled by 44.71% to $2.8 billion in 2023, then plummeted by 65.64% to $966.0 million in 2024, then rose by 5.18% to $1.0 billion in 2025.
  • Its Revenue was $1.0 billion in Q3 2025, compared to $142.0 million in Q2 2025 and $108.0 million in Q1 2025.